Magnesium and Blood Sugar

Magnesium is an essential mineral involved in over 300 enzymatic reactions in the human body — including several that directly affect insulin signaling and glucose metabolism. Its relationship to blood sugar is well-established in basic research, and the clinical evidence for benefit in adults with Type 2 diabetes who are magnesium deficient is among the more consistent in the supplement literature. Understanding that relationship — and the critical distinction between magnesium supplementation in deficient versus non-deficient adults — allows for rational, evidence-based decisions about whether magnesium supplementation is appropriate for a specific individual.

Why Magnesium Matters for Blood Sugar

Magnesium’s Role in Insulin Signaling

Magnesium acts as a cofactor for the insulin receptor tyrosine kinase — the enzyme that initiates intracellular insulin signaling. When magnesium is inadequate, this kinase functions suboptimally, impairing the cell’s ability to respond to insulin even when insulin levels are normal. The result is insulin resistance — cells require more insulin to achieve the same glucose uptake. This insulin-signaling role means that magnesium deficiency is not merely a nutritional gap — it is a direct biochemical contributor to the insulin resistance that characterizes Type 2 diabetes. Correcting magnesium deficiency in a person whose insulin resistance is partly driven by that deficiency can therefore produce measurable improvement in insulin sensitivity and glucose control. Magnesium is also required for the activity of hexokinase and phosphofructokinase — key enzymes in glucose metabolism within cells — making adequate magnesium a prerequisite for normal cellular glucose processing independent of insulin signaling effects.

Why Diabetes Increases Magnesium Deficiency Risk

Adults with Type 2 diabetes are significantly more likely to be magnesium deficient than adults without diabetes — with prevalence estimates ranging from 25–38% compared to 2–15% in the general population. This elevated deficiency rate is not primarily dietary. The main mechanism is increased urinary magnesium excretion driven by hyperglycemia. When blood glucose is elevated, the kidneys excrete more glucose in urine — and this osmotic excretion carries magnesium with it. Adults with chronically elevated blood glucose lose significantly more magnesium through their kidneys than those with well-controlled glucose. The result is a self-reinforcing cycle: elevated glucose causes magnesium loss, magnesium loss worsens insulin resistance, and worsened insulin resistance elevates glucose further. Breaking this cycle through magnesium repletion — when deficiency is confirmed — is a reasonable clinical intervention. Our blood sugar log and tracking guide covers the systematic glucose monitoring that identifies patterns of glucose elevation that drive the urinary magnesium losses perpetuating deficiency.

What the Clinical Evidence Shows

Supplementation in Magnesium-Deficient Adults

The clinical evidence for magnesium supplementation in adults with confirmed magnesium deficiency and Type 2 diabetes is genuinely positive and relatively consistent. A 2017 meta-analysis in Nutrients reviewed 18 randomized controlled trials and found that magnesium supplementation significantly reduced fasting glucose (by approximately 4–6 mg/dL on average) and improved fasting insulin — a marker of insulin resistance — compared to placebo. A 2011 meta-analysis in Diabetic Medicine found similar results, with the most significant benefit appearing in adults with baseline serum magnesium below the normal reference range. These are not large effect sizes — the average glucose reduction is smaller than berberine or metformin — but they represent a genuine, physiologically plausible, replicated clinical benefit in a specific population (deficient adults), with an excellent safety profile at standard supplementation doses.

Supplementation in Non-Deficient Adults

The evidence for magnesium supplementation in adults with normal magnesium status is less consistent. Several trials in adults without confirmed deficiency show no significant glucose benefit. This result is physiologically predictable: if the mechanism of benefit is correction of deficiency-driven impaired insulin signaling, supplementing magnesium in already-replete individuals — whose insulin receptor kinase is already functioning normally — should produce little additional benefit. This distinction has important practical implications. Magnesium supplementation is not a uniformly beneficial intervention for all adults with diabetes. It is most likely to benefit those who are actually deficient — which requires testing to determine. Taking magnesium supplementation without testing is essentially gambling on whether deficiency is present, rather than making an evidence-based decision.

Testing for Magnesium Deficiency

Serum Magnesium — Limitations and Use

The standard clinical test for magnesium status is serum magnesium — a routine blood test available through any primary care appointment. The normal reference range is typically 1.7–2.2 mg/dL (0.7–0.9 mmol/L). Adults with serum magnesium below the lower limit of normal have confirmed hypomagnesemia and have the strongest evidence-based indication for supplementation. The limitation of serum magnesium testing is that serum reflects only 1% of total body magnesium. The majority of the body’s magnesium is stored intracellularly and in bone. It is possible for serum magnesium to appear normal while intracellular magnesium is depleted — a state called functional or subclinical deficiency. This limitation means that adults whose serum is low-normal (1.7–1.9 mg/dL) but within the reference range may still have inadequate intracellular magnesium and benefit from supplementation. Discussing magnesium status testing and interpretation with your care team — particularly if you have chronically elevated glucose — is the appropriate next step before starting supplementation. Our annual diabetes care checklist covers routine laboratory tests including magnesium status assessment for adults with Type 2 diabetes.

Forms of Magnesium Supplements — Which to Choose

Absorption Differences Between Magnesium Forms

Not all magnesium supplement forms are equivalent. They differ significantly in bioavailability (the proportion absorbed from the gut) and in gastrointestinal tolerability. The most commonly available forms include:

• Magnesium glycinate: Highly bioavailable, well-tolerated, minimal laxative effect — generally the preferred form for supplementation when gastrointestinal tolerance is a concern. Higher cost than oxide.
• Magnesium citrate: Good bioavailability, more laxative effect than glycinate at higher doses — used therapeutically for constipation. Useful at lower doses for magnesium supplementation if cost is a consideration.
• Magnesium oxide: Poor bioavailability (approximately 4% absorbed) despite being the cheapest and most common form in grocery-store supplements. The dose absorbed is small relative to the labeled content — meaning a 400 mg magnesium oxide tablet delivers far less absorbed magnesium than a 200 mg magnesium glycinate tablet. Adults specifically supplementing for magnesium repletion should choose glycinate or citrate forms rather than oxide.
• Magnesium malate: Good bioavailability, well-tolerated, sometimes used for muscle function and fatigue applications — a reasonable option for blood sugar purposes with similar bioavailability to glycinate.
• Magnesium threonate: Good evidence for brain-specific magnesium increase; less established evidence specifically for glucose management; higher cost. Not the first choice for blood sugar purposes specifically.

Dosing and Safety

Standard supplementation doses for blood sugar purposes range from 200–400 mg of elemental magnesium daily — using a well-absorbed form. The tolerable upper limit for supplemental magnesium (from non-food sources) established by the Institute of Medicine is 350 mg per day for adults — above which the risk of adverse effects (primarily diarrhea and, at very high doses, more serious toxicity) increases. Dietary magnesium from food does not count toward this limit. Most people experience loose stool or diarrhea as the dose-limiting side effect at supplementation doses above 350–400 mg — reducing the dose typically resolves this. Severe magnesium toxicity (hypermagnesemia) is rare in adults with normal kidney function taking standard supplementation doses. Adults with chronic kidney disease should not supplement magnesium without nephrology or primary care guidance — impaired kidney function reduces the ability to excrete excess magnesium, increasing toxicity risk. Our supplement safety for people with diabetes guide covers kidney disease as a key contraindication for several supplements including magnesium, alongside the care team disclosure protocol for adults beginning any supplement. The broader context for magnesium within the blood sugar supplement landscape is in our supplements for blood sugar guide. The sleep improvement benefit of magnesium — relevant to adults with diabetes, where poor sleep independently worsens insulin resistance — is in our diabetes and sleep practical guide. The chromium supplement evidence — the other essential trace mineral with consistent insulin sensitivity evidence — is in our chromium and blood sugar guide. The berberine evidence — the supplement with the strongest replicated clinical glucose reduction data — is in our berberine and blood sugar guide. The cinnamon evidence and the important type-safety distinction — for adults also considering cinnamon supplementation — is in our cinnamon and blood sugar guide. The walking after meals intervention — which produces glucose reduction far greater than any supplement — is in our walking after meals for blood sugar guide. The NCCIH’s independent magnesium evidence review covers the research evidence for magnesium supplementation in diabetes and other health applications. The ADA’s vitamins and supplements guidance covers the evidence criteria for supplements in diabetes management. The NIH Office of Dietary Supplements magnesium fact sheet provides comprehensive evidence-based information on magnesium requirements, food sources, supplement forms, and upper intake limits.

Dietary Magnesium — Food-First Approach Before Supplementation

The Best Dietary Sources of Magnesium

Before considering supplementation, it is worth assessing whether dietary magnesium intake is adequate. The Recommended Dietary Allowance (RDA) for magnesium is 400–420 mg per day for adult men and 310–320 mg per day for adult women. Many adults do not meet this through diet — the US average dietary magnesium intake is approximately 250–300 mg per day, below the RDA for most men and at the lower end for women. The best food sources of magnesium are:

• Pumpkin seeds: 156 mg per ounce — the highest dietary source by weight
• Chia seeds: 111 mg per ounce
• Almonds: 80 mg per ounce
• Spinach (cooked): 78 mg per half cup
• Cashews: 74 mg per ounce
• Black beans (cooked): 60 mg per half cup
• Edamame: 50 mg per half cup
• Dark chocolate (70–85% cocoa): 50 mg per ounce
• Avocado: 44 mg per cup
• Brown rice (cooked): 42 mg per cup

These foods are also rich in fiber — which independently slows glucose absorption — protein, and other nutrients that support glucose management. Adults with diabetes or prediabetes who improve magnesium intake through these food sources simultaneously improve multiple aspects of dietary quality that benefit glucose control. The fiber-glucose connection that makes these high-magnesium foods additionally beneficial for blood sugar is in our fiber supplements and blood sugar guide.

When Dietary Intake Is Insufficient

Several factors reduce dietary magnesium availability in adults with diabetes. Medications common in diabetes management affect magnesium status: proton pump inhibitors (PPIs, used for acid reflux) significantly reduce magnesium absorption with long-term use and are a leading cause of drug-induced hypomagnesemia. Diuretics — commonly used for blood pressure and heart failure — increase urinary magnesium excretion. Adults taking these medications alongside metformin or insulin for diabetes may have multiple simultaneous drivers of magnesium depletion. When dietary intake is insufficient, medication effects are present, and/or serum magnesium is below the lower normal limit, supplementation is a reasonable clinical decision in discussion with the care team. The supplement safety framework — including reviewing all medications before starting any supplement — is in our supplement safety for people with diabetes guide.

Magnesium and Related Health Outcomes in Diabetes

Blood Pressure and Cardiovascular Risk

Adults with diabetes face substantially elevated cardiovascular risk. Magnesium deficiency independently worsens blood pressure — through effects on vascular smooth muscle relaxation and endothelial function — increasing cardiovascular risk beyond its direct glucose effects. Several meta-analyses have shown modest blood pressure reductions (2–4 mmHg systolic) with magnesium supplementation in adults with hypertension and magnesium deficiency. For adults with diabetes who also have hypertension — a very common combination — magnesium repletion may provide cardiovascular benefit alongside any glucose benefit. This dual benefit profile makes correcting magnesium deficiency particularly valuable in adults with both conditions.

Sleep Quality and Glucose Regulation

Magnesium plays a role in sleep quality through its effects on the nervous system — it activates the parasympathetic nervous system and regulates GABA receptors involved in relaxation and sleep initiation. Adults with magnesium deficiency frequently report difficulty sleeping. Poor sleep independently worsens insulin resistance and glucose control through cortisol and growth hormone pathways. Adults with diabetes whose sleep is disrupted by inadequate magnesium status may experience a cascade: magnesium deficiency impairs sleep, poor sleep worsens insulin resistance, worsened insulin resistance elevates glucose, elevated glucose increases urinary magnesium loss, and magnesium deficiency worsens further. Magnesium glycinate — the form with the best absorption and lowest gastrointestinal side effect profile — is the most commonly recommended form for adults supplementing partly for sleep quality. Our diabetes and sleep practical guide covers the full sleep-glucose connection, including sleep hygiene interventions that complement magnesium supplementation for adults whose glucose is affected by poor sleep quality.

Neuropathy and Muscle Function

Diabetic peripheral neuropathy — nerve damage causing pain, tingling, or numbness in the extremities — is associated with lower magnesium status in observational studies. The causal relationship is not fully established, but magnesium’s role in nerve conduction and its anti-inflammatory effects provide a mechanistic rationale for potential benefit. Some adults with diabetic neuropathy report symptomatic improvement with magnesium supplementation — though randomized trial evidence specifically for this outcome is limited. Magnesium is also essential for muscle function, including the prevention of muscle cramps. Nocturnal leg cramps — common in adults with diabetes and neuropathy — may improve with magnesium supplementation, independent of any direct glucose effect. This symptom benefit, even in the absence of direct glucose improvement, may be a valid reason for magnesium supplementation in specific adults. The broader building healthy habits framework — within which magnesium supplementation fits as one element of a comprehensive diabetes management approach — is in our building healthy habits with diabetes guide. The stress eating and blood sugar guide that covers cortisol’s role in driving both glucose elevation and urinary magnesium loss — creating a compounding cycle — is in our stress eating and blood sugar guide. The vitamin D and diabetes risk guide — covering another micronutrient deficiency that is common in diabetes and affects insulin sensitivity — is in our vitamin D and diabetes risk guide. The probiotics and blood sugar guide — covering the gut microbiome supplement category with emerging evidence for glucose and metabolic benefit — is in our probiotics and blood sugar guide. The annual care checklist that includes serum magnesium testing as a recommended monitoring item for adults with Type 2 diabetes is in our annual diabetes care checklist. The NIH Office of Dietary Supplements magnesium health professional fact sheet is the authoritative, non-commercial reference for magnesium requirements, food sources, supplement forms, drug interactions, and toxicity thresholds. The NCCIH magnesium evidence summary covers the research evidence for magnesium in diabetes and other health outcomes. The ADA’s vitamins and supplements guidance covers the evidence standards applied to mineral supplementation in diabetes management recommendations.

A Practical Magnesium Decision Framework for Adults With Diabetes

Step 1 — Request Serum Magnesium Testing

If you have Type 2 diabetes and have not had serum magnesium tested recently, request it at your next appointment. Serum magnesium is a standard laboratory test available through routine blood work. Mention specifically that you would like it checked — it is not always included in standard diabetes monitoring panels unless requested. If your serum magnesium is below the lower limit of normal (typically below 1.7 mg/dL or 0.7 mmol/L), you have confirmed hypomagnesemia and a clear evidence-based indication for supplementation discussion with your care team. If your result is low-normal (1.7–1.9 mg/dL) and you have chronically elevated glucose, have been taking PPI medications long-term, or take a diuretic, discuss with your provider whether supplementation is reasonable given the functional deficiency possibility. Our doctor visit checklist for diabetes guide covers how to prepare for appointments in a way that ensures all relevant tests — including magnesium — are ordered and interpreted in context.

Step 2 — Increase Dietary Magnesium First

Before starting supplementation, assess whether dietary magnesium can be meaningfully increased. Adding one or two high-magnesium foods daily — a daily serving of pumpkin seeds, almonds, or spinach — provides 50–150 mg of highly bioavailable dietary magnesium with additional fiber, protein, and healthy fat benefits. For adults whose dietary intake is already close to the RDA and whose serum magnesium is deficient, dietary improvement alone may be insufficient — supplementation is appropriate in this context. For adults whose dietary magnesium is very low (typical of highly processed food diets), dietary improvement may alone address deficiency without supplementation. The building healthy habits approach that integrates dietary changes — including increasing magnesium-rich foods — into a sustainable daily routine is in our building healthy habits with diabetes guide.

Step 3 — Choose Magnesium Glycinate at 200–300 mg/day

If supplementation is appropriate, start with magnesium glycinate at 200 mg of elemental magnesium per day — taken with a meal to reduce gastrointestinal effects. After 4–6 weeks, retest serum magnesium to confirm repletion. If serum remains below normal, the dose can be increased to 300–350 mg per day, staying below the 350 mg tolerable upper limit for supplemental magnesium. Do not exceed 350 mg of supplemental elemental magnesium daily without care team guidance. If gastrointestinal side effects occur (loose stool, diarrhea), reduce the dose — these effects are dose-dependent and reversible. Inform your care team and pharmacist of the supplementation — both to ensure it is noted in your medical record and to check for interactions with any medications you take. The chromium supplement — the other essential trace mineral with consistent modest insulin sensitivity evidence — is in our chromium and blood sugar guide. The berberine supplement — the option with the strongest replicated clinical glucose reduction data across multiple meta-analyses — is in our berberine and blood sugar guide. The supplements for blood sugar overview that places magnesium within the full landscape of commonly used blood sugar supplements and their relative evidence quality is in our supplements for blood sugar guide. The supplement safety guide that covers the kidney disease contraindication for magnesium supplementation — the most important safety concern for adults with diabetic kidney disease — is in our supplement safety for people with diabetes guide.

Magnesium and Exercise Performance in Adults With Diabetes

Why Magnesium Matters During Physical Activity

Physical activity is one of the most effective glucose management tools available — post-meal walking, resistance training, and aerobic exercise all produce meaningful glucose reduction through multiple mechanisms. Magnesium is essential for the energy production that physical activity requires. It is a cofactor for ATP synthesis in the mitochondria — every muscle contraction depends on ATP, and ATP production depends on adequate magnesium. Magnesium-deficient adults therefore have reduced exercise capacity — they fatigue more quickly, recover more slowly, and produce less power per unit of effort than magnesium-replete adults. This performance limitation applies both to the subjective experience of exercise (which influences adherence) and to the metabolic benefit produced (which influences glucose outcomes). Correcting magnesium deficiency in adults with diabetes who exercise regularly may improve both exercise tolerance and the glucose benefit they derive from exercise. The safe exercise framework for adults with diabetes — including glucose monitoring before, during, and after exercise — is in our safe exercise with diabetes guide. The strength training evidence specifically for Type 2 diabetes glucose management — the exercise modality that most consistently improves insulin sensitivity long-term — is in our strength training for Type 2 diabetes guide. Magnesium repletion that supports better exercise performance creates a compounding benefit — better exercise produces better glucose control, which reduces urinary magnesium loss, which maintains better magnesium status for the next exercise session. This positive cycle is the opposite of the depletion cycle that uncorrected deficiency produces.

Sources: Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World Journal of Diabetes 2015; Guerrero-Romero F et al. Magnesium in metabolic syndrome. Magnesium Research 2009; Veronese N et al. Magnesium and health outcomes. Nutrients 2021; NIH Office of Dietary Supplements Magnesium Fact Sheet 2024; NCCIH Magnesium Evidence Review 2024; ADA Standards of Care in Diabetes 2024.